相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Role of nitric oxide in the regulation of T cell functions
W. Niedbala et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Antioxidants in multiple sclerosis - Do they have a role in therapy?
Noel G. Carlson et al.
CNS DRUGS (2006)
Immunological patterns identifying disease course and evolution in multiple sclerosis patients
R Furlan et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Th1 and Th2 lymphocyte migration across the human BBB is specifically regulated by interferon β and copolymer-1
A Prat et al.
JOURNAL OF AUTOIMMUNITY (2005)
Multiple sclerosis:: glatiramer acetate inhibits monocyte reactivity in vitro and in vivo
MS Weber et al.
BRAIN (2004)
Inducible nitric oxide synthase in chronic active multiple sclerosis plaques: distribution, cellular expression and association with myelin damage
KE Hill et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
Glatiramer acetate-specific T cells in the brain express T helper 2/3 cytokines and brain-derived neurotrophic factor in situ
R Aharoni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Nitric oxide metabolite determinations reveal continuous inflammation in multiple sclerosis
AI Danilov et al.
JOURNAL OF NEUROIMMUNOLOGY (2003)
Blood-brain barrier disruption in multiple sclerosis
A Minagar et al.
MULTIPLE SCLEROSIS JOURNAL (2003)
Serum nitric oxide metabolites in patients with multiple sclerosis
B Nazliel et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2002)
The role of nitric oxide in multiple sclerosis
KJ Smith et al.
LANCET NEUROLOGY (2002)
Glatiramer acetate - A review of its use in relapsing-remitting multiple sclerosis
D Simpson et al.
CNS DRUGS (2002)
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis
WI McDonald et al.
ANNALS OF NEUROLOGY (2001)
Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions
JSH Liu et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Serum inflammatory markers and clinical/MRI markers of disease progression in multiple sclerosis
G Giovannoni et al.
JOURNAL OF NEUROLOGY (2001)
European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging-measured disease activity and burden in patients with relapsing multiple sclerosis
G Comi et al.
ANNALS OF NEUROLOGY (2001)
Glatiramer acetate (Copaxone®) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis
PW Duda et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
分享论文
